Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 18510766)

1.

Nef does not contribute to replication differences between R5 pre-AIDS and AIDS HIV-1 clones from patient ACH142.

Olivieri KC, Scoggins RM, Broderick B, Powell ML, Alexander MA, Hammarskjöld ML, Rekosh D, Camerini D.

Retrovirology. 2008 May 29;5:42. doi: 10.1186/1742-4690-5-42.

2.

HIV Nef: role in pathogenesis and viral fitness.

Ariën KK, Verhasselt B.

Curr HIV Res. 2008 May;6(3):200-8. Review.

PMID:
18473783
3.

Role of CD4 receptor down-regulation during HIV-1 infection.

Levesque K, Finzi A, Binette J, Cohen EA.

Curr HIV Res. 2004 Jan;2(1):51-9. Review.

PMID:
15053340
4.

Role of the CD4 down-modulation activity of Nef in HIV-1 infectivity.

Doria M.

Curr HIV Res. 2011 Oct;9(7):490-5. Review.

PMID:
22103832
5.

HIV-1 Nef: a critical factor in viral-induced pathogenesis.

Greenway AL, Holloway G, McPhee DA.

Adv Pharmacol. 2000;48:299-343. Review. No abstract available.

PMID:
10987095
6.

Modelling thymic HIV-1 Nef effects.

Stove V, Verhasselt B.

Curr HIV Res. 2006 Jan;4(1):57-64. Review.

PMID:
16454711
7.

Nef: "necessary and enforcing factor" in HIV infection.

Joseph AM, Kumar M, Mitra D.

Curr HIV Res. 2005 Jan;3(1):87-94. Review.

PMID:
15638726
8.
9.

The impact of viral and host elements on HIV fitness and disease progression.

Henry KR, Weber J, Quiñones-Mateu ME, Arts EJ.

Curr HIV/AIDS Rep. 2007 Feb;4(1):36-41. Review.

PMID:
17338859
10.

The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control.

Zaunders J, Dyer WB, Churchill M.

Curr Opin HIV AIDS. 2011 May;6(3):151-6. doi: 10.1097/COH.0b013e3283454d5b. Review.

PMID:
21378562
11.

[Functional roles of HIV-1 accessory genes for its pathogenicity].

Adachi A, Kamada K, Hatcho K, Yamashita T, Uchiyama T, Nomaguchi M.

Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1261-7. Review. Japanese. No abstract available.

PMID:
17824250
12.

Immunoregulatory effects of HIV-1 Nef protein.

Quaranta MG, Mattioli B, Giordani L, Viora M.

Biofactors. 2009 Mar-Apr;35(2):169-74. doi: 10.1002/biof.28. Review.

PMID:
19449444
13.

Role of Nef in HIV-1 replication and pathogenesis.

Foster JL, Garcia JV.

Adv Pharmacol. 2007;55:389-409. Review. No abstract available.

PMID:
17586321
14.

HIV-1 Nef: at the crossroads.

Foster JL, Garcia JV.

Retrovirology. 2008 Sep 22;5:84. doi: 10.1186/1742-4690-5-84. Review.

15.

The interaction of HIV-1 with the host factors.

Komano J, Futahashi Y, Urano E, Miyauchi K, Murakami T, Matsuda Z, Yamamoto N.

Jpn J Infect Dis. 2005 Jun;58(3):125-30. Review.

16.

Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?

Richter SN, Frasson I, Palù G.

Curr Med Chem. 2009;16(3):267-86. Review.

PMID:
19149577
17.

HIV accessory proteins and surviving the host cell.

Anderson JL, Hope TJ.

Curr HIV/AIDS Rep. 2004 Apr;1(1):47-53. Review.

PMID:
16091223
18.

Role of Nef in primate lentiviral immunopathogenesis.

Kirchhoff F, Schindler M, Specht A, Arhel N, Münch J.

Cell Mol Life Sci. 2008 Sep;65(17):2621-36. doi: 10.1007/s00018-008-8094-2. Review.

PMID:
18438604
19.

Getting to know HIV.

Weiss RA.

Trop Med Int Health. 2000 Jul;5(7):A10-5. Review.

20.

A brief history of TRIM5alpha.

Newman RM, Johnson WE.

AIDS Rev. 2007 Apr-Jun;9(2):114-25. Review.

PMID:
17694678
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk